161 related articles for article (PubMed ID: 8937728)
1. Increased activity of guanylate cyclase in the atherosclerotic rabbit aorta: role of non-endothelial nitric oxide synthases.
Rupin A; Behr D; Verbeuren TJ
Br J Pharmacol; 1996 Nov; 119(6):1233-8. PubMed ID: 8937728
[TBL] [Abstract][Full Text] [Related]
2. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
[TBL] [Abstract][Full Text] [Related]
3. Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.
Sadoff JD; Scholz PM; Tse J; Weiss HR
J Clin Invest; 1996 Aug; 98(3):838-45. PubMed ID: 8698876
[TBL] [Abstract][Full Text] [Related]
4. Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin.
Fleming I; Julou-Schaeffer G; Gray GA; Parratt JR; Stoclet JC
Br J Pharmacol; 1991 May; 103(1):1047-52. PubMed ID: 1678981
[TBL] [Abstract][Full Text] [Related]
5. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
Davidov T; Weiss HR; Tse J; Scholz PM
Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448
[TBL] [Abstract][Full Text] [Related]
6. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
[TBL] [Abstract][Full Text] [Related]
7. Role of nitric oxide and cyclic GMP in the dizocilpine-induced impairment of spontaneous alternation behavior in mice.
Yamada K; Hiramatsu M; Noda Y; Mamiya T; Murai M; Kameyama T; Komori Y; Nikai T; Sugihara H; Nabeshima T
Neuroscience; 1996 Sep; 74(2):365-74. PubMed ID: 8865189
[TBL] [Abstract][Full Text] [Related]
8. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
[TBL] [Abstract][Full Text] [Related]
9. Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.
Hussain MB; Hobbs AJ; MacAllister RJ
Br J Pharmacol; 1999 Nov; 128(5):1082-8. PubMed ID: 10556946
[TBL] [Abstract][Full Text] [Related]
10. Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta.
Zembowicz A; Hatchett RJ; Jakubowski AM; Gryglewski RJ
Br J Pharmacol; 1993 Sep; 110(1):151-8. PubMed ID: 7693274
[TBL] [Abstract][Full Text] [Related]
11. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
Yu SM; Kuo SC
Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926
[TBL] [Abstract][Full Text] [Related]
12. Neuronal nitric oxide synthase and its interaction with soluble guanylate cyclase is a key factor for the vascular dysfunction of experimental sepsis.
Nardi GM; Scheschowitsch K; Ammar D; de Oliveira SK; Arruda TB; Assreuy J
Crit Care Med; 2014 Jun; 42(6):e391-400. PubMed ID: 24717470
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying relaxation of rabbit aorta by BAY 41-2272, a nitric oxide-independent soluble guanylate cyclase activator.
Priviero FB; Baracat JS; Teixeira CE; Claudino MA; De Nucci G; Antunes E
Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):728-34. PubMed ID: 16173929
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting cyclic guanosine-3',5'-monophosphate accumulation in the medium of cultured smooth muscle cells from atherosclerotic rabbit aortas in response to exogenous or endogenous nitric oxide.
Rupin A; Behr-Roussel D; Verbeuren TJ
Fundam Clin Pharmacol; 2000; 14(5):453-9. PubMed ID: 11129085
[TBL] [Abstract][Full Text] [Related]
15. Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta.
Moritoki H; Hisayama T; Takeuchi S; Miyano H; Kondoh W
Br J Pharmacol; 1992 Sep; 107(1):196-201. PubMed ID: 1358382
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity.
Fernandes D; da Silva-Santos JE; Duma D; Villela CG; Barja-Fidalgo C; Assreuy J
Mol Pharmacol; 2006 Mar; 69(3):983-90. PubMed ID: 16326931
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
Handy RL; Moore PK
Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous measurement of endothelium-derived relaxing factor by bioassay and guanylate cyclase stimulation.
Kondo K; Mitchell JA; de Nucci G; Vane JR
Br J Pharmacol; 1989 Oct; 98(2):630-6. PubMed ID: 2573403
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-donating compounds and cyclic GMP depress the spontaneous contractile activity of the isolated rabbit jejunum.
Izzo AA; Mascolo N; Maiolino P; Capasso F
Pharmacology; 1996 Aug; 53(2):109-13. PubMed ID: 8902875
[TBL] [Abstract][Full Text] [Related]
20. Dietary L-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbits.
Böger RH; Bode-Böger SM; Kienke S; Stan AC; Nafe R; Frölich JC
Atherosclerosis; 1998 Jan; 136(1):67-77. PubMed ID: 9544733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
